Vivo

Vivo recently confirmed the T2 Pro 5G smartphone in India. The Chinese brand has not revealed the launch date of T2 Pro 5G. The launch date announcement has also revealed the design of the upcoming T2 Pro 5G, and it looks exactly…

In a step forward in the development of genetic medicines, researchers at Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania have developed a proof-of-concept model for…

Oppo Mobile, Vivo India, and Xiaomi Technology…

New Findings Support Development of Racemic Tianeptine and (S)-Tianeptine (Estianeptine) as First-in-Class Oral Therapies in Alzheimer’s Disease and Other Psychiatric and Neurodegenerative Conditions with Memory Deficits (S)-Tianeptine…

Vivo Y27 5G and Vivo Y27 4G have been spotted on many certifications websites and now they have been spotted on NBTC certifications websites as well. The Vivo Y27 5G is said to be the rebranded version of Vivo Y36 5G. On the other…

Reading Time: 2 minutes  nanocosmos at Sigma Asia: Expanded reach for nanoStream Cloud to deliver high-quality interactive streaming of live games and bets in Asia nanocosmos, a leading real-time video streaming provider,…

Reading Time: 3 minutes  Vivo, a global leading technology company, announced that it has been named the Official Exclusive Supplier of Mobile Phones for the 19th Asian Games Hangzhou (Hangzhou Asian Games) on June 15. This…

Verve to Receive $60 Million in Combined Upfront Payment and Equity Investment; Additional Capital Positioned to Extend Verve’s Expected Cash Runway into 2026 Verve has Opt-in Rights to Co-fund and Share in Potential Margins of Products…

Extended Phase 1 data reinforce the potential of NTLA-2002 to be a functional cure for people living with hereditary angioedema (HAE)Across all patients (n=10), a single dose of NTLA-2002 led to a 95% mean reduction in monthly HAE attack…

ALLSCHWIL, Switzerland, June 06, 2023 (GLOBE NEWSWIRE) -- Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on rare diseases and oncology, today announced the publication of preclinical results from the company’s…